SEC Filings for CollPlant Biotechnologies Ltd. (CLGN)

$ 10.30   0.48 (+4.89%) Volume: 3.69k 10:56 AM EDT May 29, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934502/04/2019
F-3Registration statement for securities of certain foreign private issuers4102/01/2019
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1101/08/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934301/02/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934312/14/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934512/10/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341011/29/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934511/13/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341611/01/2018
CT ORDERConfidential treatment order110/30/2018
F-1Registration statement for securities of certain foreign private issuers7110/30/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934410/29/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19346810/25/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934610/22/2018
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19343209/21/2018
123456789